arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Tevogen Bio Holdings Inc.

TVGN

$6.20 ▼ -0.29 (-4.55%) at close

22 Visible periods

20 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Neutral Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Tevogen Bio Holdings Inc. shows mixed fundamentals. Return on Invested Capital remain bright spots. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $21.6M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 43.4% →

FCF / Share $-0.78

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

22-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-5.45M

↑ +47.5% —

FCF / Share Free cash flow per share

$-0.78

↓ -3726.1% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

Return on Invested CapitalReturn on Invested Capital of 250.8% is excellent on an absolute basis (target > 10%)

warning

Bearish Risks

Interest CoverageInterest Coverage of -133.63x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.47x is weak on an absolute basis (target > 1x)

Health Breakdown

Financial Health ↓

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Apr 20, 2021 10-Q ↗	Q4 FY2020 Apr 21, 2021 10-K ↗
EPS Growth YoY (%)	-2200.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-128.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	25.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-2392.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	77.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	47.5% Excellent Excellent Year-over-year change in net income	50.5% Excellent Excellent Year-over-year change in net income	N/M	N/M	N/M	-160.0% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	N/M	-118247.5% Weak → Weak Stable Year-over-year change in net income	-118247.5% Weak ↓ Weak Declining Year-over-year change in net income	-118247.5% Weak ↓ Weak Declining Year-over-year change in net income	—	-272.2% Weak Weak Year-over-year change in net income	-130.0% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	-3726.1% Weak Weak Year-over-year change in free cash flow	—	—	—	-30.1% Weak Weak Year-over-year change in free cash flow	—	—	—	18.2% Good Good Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Apr 20, 2021 10-Q ↗	Q4 FY2020 Apr 21, 2021 10-K ↗
FCF / Net Income (x)	0.50x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.35x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.31x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	0.32x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.32x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	-0.19x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.06x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.07x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.08x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	-0.01x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	4.35x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Apr 20, 2021 10-Q ↗	Q4 FY2020 Apr 21, 2021 10-K ↗
Return on Invested Capital (%)	43.4% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	44.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	57.9% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	45.3% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	106.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	110.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	77.7% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	89.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	401.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	1.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	2.8% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—	—	—	—	—	—
Return on Capital (%) (%)	-109.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-105.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-127.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-127.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-254.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-270.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-141.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-259.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-877.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	-36.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	55.3% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+269%)	56.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+279%)	132.5% Excellent → Excellent Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+783%)	109.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+629%)	134.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+795%)	141.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+843%)	-182.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1313%)	-147.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1084%)	-194.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1394%)	3.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-74%)	33.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+126%)	35.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+136%)	47.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+217%)	-17.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-218%)	0.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-99%)	0.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-99%)	0.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-99%)	—	-51.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-443%)	-82.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-650%)	—	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Apr 20, 2021 10-Q ↗	Q4 FY2020 Apr 21, 2021 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—	—	—	—	—
Interest Coverage (x)	-75.89x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-65.23x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-91.91x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-143.15x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-421.49x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-592.68x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-488.44x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-189.47x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6.33x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-7.75x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-7.28x Weak Weak Operating income divided by interest expense Optimal: > 5x	-8.04x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—
Net Debt (USD)	—	$0.00	—	—	—	$0.00	—	—	—	$0.00	—	—	—	$0.00	$-143.05K	$-185.65K	$-231.55K	$-344.58K	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Apr 20, 2021 10-Q ↗	Q4 FY2020 Apr 21, 2021 10-K ↗
Basic EPS, GAAP (USD)	$-1.61	$-7.96	$-0.03	$-0.03	$-0.07	$-3.49	$-0.03	$-0.04	$0.08	$-0.14	$-0.03	$-0.18	$-0.26	—	—	—	—	—	$0.00	—	—	—
Free Cash Flow per Share (USD)	$-0.78	—	$-0.02	$-0.02	$-0.02	—	—	—	$-0.02	—	$-0.01	$-0.02	$-0.02	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-2.36	$-2.05	$-0.04	$-0.05	$-0.04	$-1.87	$-0.04	$-0.05	$-0.04	$-0.79	$-0.76	$-0.72	$-0.54	—	—	—	—	—	$0.00	—	—	—
Tangible Book Value per Share (USD)	$-2.36	$-2.05	$-0.04	$-0.05	$-0.04	$-1.87	$-0.04	$-0.05	$-0.04	$-0.79	$-0.76	$-0.72	$-0.54	—	—	—	—	—	$0.00	—	—	—
Basic Weighted Avg Shares (shares)	3.49M	—	196.03M	184.31M	161.41M	—	170.17M	154.17M	137.33M	—	120.00M	120.00M	120.00M	—	—	—	—	—	10.32M	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Apr 20, 2021 10-Q ↗	Q4 FY2020 Apr 21, 2021 10-K ↗
Working Capital (USD)	$-5.13M	$-5.53M	$-4.62M	$-6.02M	$-5.64M	$-6.68M	$-6.89M	$-8.17M	$-6.54M	$-83.76M	—	—	—	$-76.10K	$136.69K	$335.52K	$555.16K	$731.82K	—	—	—	—
Total Equity (USD)	$-9.84M	$-8.23M	$-7.82M	$-9.48M	$-7.72M	$-6.67M	$-6.19M	$-7.63M	$-5.80M	$-94.43M	$-90.80M	$-86.89M	$-64.71M	$-14.78M	$-14.66M	$-14.05M	$-14.25M	$-14.23M	$13.59K	$13.70K	$0.00	$0.00

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Apr 20, 2021 10-Q ↗	Q4 FY2020 Apr 21, 2021 10-K ↗
Depreciation Expense (USD)	$30.27K	$58.06K	$518.00	$91.44K	$40.55K	$40.55K	—	—	$40.55K	$44.09K	$39.73K	$39.74K	$39.73K	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-5.45M	$-4.68M	$-10.37M	$-10.37M	$-10.37M	$-9.44M	$11.26M	$11.26M	$11.26M	$-3.63M	$-30.76M	$-30.76M	$-30.76M	$2.61M	$-25.99K	$-25.99K	$-25.99K	—	$-6.98K	$-11.30K	—	—
Operating Cash Flow (USD)	$-2.73M	$-2.18M	$-3.65M	$-3.19M	$-3.31M	$-3.05M	—	—	$-2.16M	$-1.98M	$-1.80M	$-2.22M	$-2.18M	$-13.86K	—	—	$-113.03K	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 22 quarters

Tevogen Bio Holdings Inc.

Analytical Summary

22-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare TVGN with peers